Effect of non‐recommended doses versus recommended doses of direct oral anticoagulants in atrial fibrillation patients: A meta‐analysis
X Liu, M Huang, C Ye, X Xiao, C Yan - Clinical Cardiology, 2021 - Wiley Online Library
Background Several observational studies have shown that the inappropriate dosing use of
direct oral anticoagulants (DOACs) in atrial fibrillation (AF) that does not conform to …
direct oral anticoagulants (DOACs) in atrial fibrillation (AF) that does not conform to …
Direct oral anticoagulants as the first choice of anticoagulation for patients with peripheral artery disease to prevent adverse vascular events: a systematic review and …
The best method of anticoagulation for patients with peripheral artery disease (PAD) is still a
topic of interest for physicians. We conducted a meta-analysis to compare the effects of …
topic of interest for physicians. We conducted a meta-analysis to compare the effects of …
Comparative effectiveness and safety of non–vitamin K antagonist oral anticoagulants in atrial fibrillation patients
W Zhu, Z Ye, S Chen, D Wu, J He, Y Dong, GYH Lip… - Stroke, 2021 - Am Heart Assoc
Background and Purpose: Several observational studies have compared the effect of the
non–vitamin K antagonist oral anticoagulants to each other in patients with atrial fibrillation …
non–vitamin K antagonist oral anticoagulants to each other in patients with atrial fibrillation …
[PDF][PDF] Arzneimittelreport 2021
D Grandt, V Lappe - Berlin: Barmer, 2021 - bifg.de
Die Arzneimitteltherapie bei Frauen im gebärfähigen Alter ist jedoch schlecht dokumentiert.
Das geht aus unseren Umfrageergebnissen hervor. Nur wenige Frauen, die bereits vor ihrer …
Das geht aus unseren Umfrageergebnissen hervor. Nur wenige Frauen, die bereits vor ihrer …
Reappraisal of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients: a systematic review and meta-analysis
Background: Recent observational studies have compared effectiveness and safety profiles
between non-vitamin K antagonist oral anticoagulants (NOACs) and warfarin in patients with …
between non-vitamin K antagonist oral anticoagulants (NOACs) and warfarin in patients with …
Non‐vitamin K antagonist oral anticoagulants versus vitamin K antagonists in atrial fibrillation patients with previous stroke or intracranial hemorrhage: A systematic …
Z Guo, X Ding, Z Ye, W Chen, Y Chen - Clinical Cardiology, 2021 - Wiley Online Library
Several observational studies have compared the effectiveness and safety outcomes
between nonvitamin K antagonist oral anticoagulants (NOACs) and vitamin K antagonists …
between nonvitamin K antagonist oral anticoagulants (NOACs) and vitamin K antagonists …
Expression of anti and pro‐inflammatory genes in human endothelial cells activated by 25‐hydroxycholesterol: A comparison of rivaroxaban and dabigatran
P Gorzelak‐Pabiś, A Pawlos, M Broncel… - Clinical and …, 2022 - Wiley Online Library
Atherosclerosis is associated with a haemostatic imbalance characterized by excessive
activation of pro‐inflammatory and pro‐coagulant pathways. Non‐vitamin K antagonists oral …
activation of pro‐inflammatory and pro‐coagulant pathways. Non‐vitamin K antagonists oral …
[HTML][HTML] Vascular Impairment, Muscle Atrophy, and Cognitive Decline: Critical Age-Related Conditions
The triad of vascular impairment, muscle atrophy, and cognitive decline represents critical
age-related conditions that significantly impact health. Vascular impairment disrupts blood …
age-related conditions that significantly impact health. Vascular impairment disrupts blood …
The role of non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: a PRISMA-compliant article
X Liu, M Huang, C Ye, J Zeng, C Zeng, J Ma - Medicine, 2020 - journals.lww.com
Background: Given the huge burden of atrial fibrillation (AF) and AF-related stroke in Asia,
stroke prevention represents an urgent issue in this region. We herein performed a network …
stroke prevention represents an urgent issue in this region. We herein performed a network …
Association of direct oral anticoagulants vs. vitamin K antagonists with fractures in atrial fibrillation patients: a systematic review and meta-analysis
X Wu, L Hu, J Liu, Q Gu - Frontiers in Cardiovascular Medicine, 2021 - frontiersin.org
Background: Current evidence regarding the application of direct oral anticoagulants
(DOACs) vs. vitamin K antagonists (VKAs) on the fracture risk is inconsistent. Therefore, we …
(DOACs) vs. vitamin K antagonists (VKAs) on the fracture risk is inconsistent. Therefore, we …